Cleared Traditional

K200990 - VIDAvision

K200990 is the FDA 510(k) clearance for VIDAvision by Vida Diagnostics, Inc.. It is a Class 2 Radiology device (product code JAK) cleared through the Traditional 510(k) pathway after a 114-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2020
Decision
114d
Days
Class 2
Risk

K200990 is an FDA 510(k) clearance for the VIDAvision. Classified as System, X-ray, Tomography, Computed (product code JAK), Class II - Special Controls.

Submitted by Vida Diagnostics, Inc. (Coralville, US). The FDA issued a Cleared decision on August 7, 2020 after a review of 114 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1750 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Vida Diagnostics, Inc. devices

Submission Details

510(k) Number K200990 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 15, 2020
Decision Date August 07, 2020
Days to Decision 114 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
7d slower than avg
Panel avg: 107d · This submission: 114d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JAK System, X-ray, Tomography, Computed
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - JAK System, X-ray, Tomography, Computed

All 581
Devices cleared under the same product code (JAK) and FDA review panel - the closest regulatory comparables to K200990.
LSN
K201092 · Imaging Biometrics, LLC · Oct 2020
syngo.CT Neuro Perfusion
K202213 · Siemens Medical Solutions USA, Inc. · Oct 2020
Clear Guide SCENERGY
K201188 · Clear Guide Medical · Sep 2020
Clear Guide SCENERGY
K201898 · Clear Guide Medical · Jul 2020
SOMATOM On.site and On.scene
K193277 · Siemens Medical Solutions USA, Inc. · Jul 2020
SCENARIA View
K200498 · Hitachi Healthcare Americas · Jul 2020